Tardive dyskinesia and atypical antipsychotic drugs

@article{Casey1999TardiveDA,
  title={Tardive dyskinesia and atypical antipsychotic drugs},
  author={D. Casey},
  journal={Schizophrenia Research},
  year={1999},
  volume={35},
  pages={S61-S66}
}
  • D. Casey
  • Published 1999
  • Medicine, Psychology
  • Schizophrenia Research
Typical antipsychotic agents produce central nervous system effects, especially extrapyramidal symptoms (EPS) and tardive dyskinesia (TD). Nearly every patient who receives neuroleptic therapy has one or more identifiable risk factors for TD, among the most significant of which are older age, female gender, presence of EPS, diabetes mellitus, affective disorders, and certain parameters of neuroleptic exposure (i.e. dose and duration of therapy). The typical course of TD is a gradual onset after… Expand
Tardive dyskinesia in elderly patients: an update.
  • R. Goldberg
  • Medicine
  • Journal of the American Medical Directors Association
  • 2003
Extrapyramidal Symptoms with Atypical Antipsychotics
Untitled Page
Tardive Dyskinesia: Treatment with Aripiprazole
  • N. Kang, Moon-Doo Kim
  • Medicine
  • Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
  • 2011
Historical perspectives on tardive dyskinesia
Tardive dyskinesias and antipsychotics: a review
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Treatment of tardive dyskinesia.
Tardive dyskinesia and diabetes mellitus.
Tardive dyskinesia in the aged. Duration of treatment relationships.
Tardive dyskinesia in older out‐patients: a follow‐up study
The differential diagnosis of tardive dyskinesia
  • D. Casey
  • Psychology, Medicine
  • Acta psychiatrica Scandinavica. Supplementum
  • 1981
Tardive dyskinesia: a 3-year follow-up study.
...
1
2
3
4
...